The project will focus on testing 5G networks for software-centric architectures. Photo via Getty Images

A team of Rice University engineers has secured a $1.9 million grant from the U.S. Department of Commerce’s National Telecommunications and Information Administration to develop a new way to test 5G networks.

The project will focus on testing 5G networks for software-centric architectures, according to a statement from Rice. The funds come from the NTIA's most recent round of grants, totaling about $80 million, as part of the $1.5 billion Public Wireless Supply Chain Innovation Fund. Other awards went to Virginia Tech, Northeastern University, DISH Wireless, and more.

The project at Rice will be led by Rahman Doost-Mohammady, an assistant research professor of electrical and computer engineering; and Ashutosh Sabharwal, the Ernest Dell Butcher Professor of Engineering and chair of the Department of Electrical and Computer Engineering. Santiago Segarra, assistant professor of electrical and computer engineering and an expert in machine learning for wireless network design, is also a co-principal investigator on this project.

"Current testing methodologies for wireless products have predominantly focused on the communication dimension, evaluating aspects such as load testing and channel emulation,” said Doost-Mohammady said in a statement. “But with the escalating trend toward software-based wireless products, it’s imperative that we take a more holistic approach to testing."

The new framework will be used to "assess the stability, interoperability, energy efficiency and communication performance of software-based machine learning-enabled 5G radio access networks (RANs)," according to Rice, known as ETHOS.

Once created, the team of researchers will use the framework for extensive testing using novel machine learning algorithms for 5G RAN with California-based NVIDIA's Aerial Research Cloud (ARC) platform. The team also plans to partner with other industry contacts in the future, according to Rice.

“The broader impacts of this project are far-reaching, with the potential to revolutionize software-based and machine learning-enabled wireless product testing by making it more comprehensive and responsive to the complexities of real-world network environments,” Sabharwal said in the statement. “By providing the industry with advanced tools to evaluate and ensure the stability, energy efficiency and throughput of their products, our research is poised to contribute to the successful deployment of 5G and beyond wireless networks.”

Late last year, the Houston location of Greentown Labs also landed funds from the Department of Commerce. The climatetech startup incubator was named to of the Economic Development Administration's 10th cohort of its Build to Scale program and will receive $400,000 with a $400,000 local match confirmed.

Houston-based nonprofit accelerator, BioWell, also received funding from the Build to Scale program.
Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

European spacecraft developer expands to Houston with U.S. business, new lab

houston hq

European aerospace manufacturer The Exploration Company has established its first U.S. entity and named Space City as its headquarters.

The company announced earlier this month that it has launched TEC Federal to support U.S. government customers and agencies, and to scale The Exploration Company's engineering operations in the country.

Mark Kirasich serves as president of TEC Federal. Kirasich most recently served as the senior director of human spaceflight at Blue Origin after a nearly 40-year career at NASA.

The Exploration Company is developing the reusable Nyx space vehicle. Nyx is designed to take off from any heavy launcher in the world. It will then dock at space stations, retrieve up to 3,000 kilograms of cargo, splash down and return the cargo to Earth. The company aims to make Nyx fully reusable for up to 10 missions, making it a more affordable and sustainable option for aerospace missions.

The Exploration Company completed a successful drop test of the spacecraft in May in the Mojave Desert. The company says Nyx is slated to perform its first flight demonstration in 2028.

In addition to launching the Houston business, The Exploration Company also opened its new Rapid Innovation Lab near Houston's NASA Johnson Space Center on Space Park Drive.

The Exploration Company opened its Rapid Innovation Lab earlier this month. Photo via LinkedIn

The Rapid Innovation Lab features a full-scale mockup of the future Nyx crew capsule as well as ongoing development and testing of the Nyx cargo capsule, according to the company.

The Exploration Company says the new lab will allow its engineers, designers, and operators to prototype and test crew interfaces. It will also support partnerships with NASA personnel and astronauts.

“Houston gives us direct access to the people and expertise that have built and operated human spaceflight systems for decades. We’re excited to invest and expand around that— engineers, operators, and astronauts working together and moving quickly towards building a crew capsule.” Hélène Huby, founder and CEO of The Exploration Company, said in a blog post.

According to The Houston Chronicle, The Exploration Company has about 30 employees in the Houston area.

The company was founded in 2021 by Huby, a French rocket scientist, and has raised more than $350 million in venture capital. It operates out of Germany, France, Luxembourg, Spain and Italy, with offices in the U.S. and the United Arab Emirates. It is also developing a reusable, high-thrust rocket engine known as Storm.

UH lands $4M NIH grant to study early signs of autoimmune disease

NIH funding

The University of Houston recently received a $4 million National Institutes of Health grant to support a 10-year longitudinal study to identify the earliest biological markers of autoimmune disease.

Led by Chandra Mohan, the Hugh Roy and Lillie Cranz Cullen Endowed Professor of Biomedical Engineering, the study aims to examine what causes Systemic Autoimmune Rheumatic Diseases (SARDs) and to identify targets for future treatments. The study will be carried out in collaboration with Dr. Karen Costenbader at Harvard Medical School, Boston.

SARDs include conditions like rheumatoid arthritis, systemic lupus erythematosus, Sjögren’s syndrome and systemic sclerosis—all are considered chronic diseases currently without a cure. Autoimmune diseases affect over 30 million people globally, according to UH.

SARDs occur when the body’s immune system attacks healthy, non-threatening tissues and organs. According to UH, in these diseases, the body often attacks nuclear antigens, creating anti-nuclear autoantibodies, which can be early detection signs for SARDs in more than 50 percent of patients, Mohan says.

Researchers will study blood samples and environmental exposure over the 10 years to better understand anti-nuclear autoantibodies.

“Collectively, these studies will help identify the genetic, environmental and cellular factors that are operative at the two steps of SARD development, namely the emergence of anti-nuclear autoantibodies and disease onset,” Mohan said in a news release. “ More importantly, these studies will highlight functional molecular pathways and mechanisms that may be operative at each step."

Mohan predicts that looking at SARDs’ shared characteristics, rather than each disease individually, could help identify more treatment methods.

“Individual SARDs have been examined in silos without an attempt to discern shared underlying features at the molecular level,” he added in the release. “Current understanding of the initial (and likely shared) origins of SARDs is only rudimentary but urgently needed to develop means for prevention and treatment.”

Earlier this year, UH also received an $11 million NIH grant to conduct a first-of-its-kind study of early language development in children ages 18 to 24 months. Read more here.